Zhejiang Chimin Pharm Co Ltd - Asset Resilience Ratio

Latest as of September 2024: 4.12%

Zhejiang Chimin Pharm Co Ltd (603222) has an Asset Resilience Ratio of 4.12% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Explore Zhejiang Chimin Pharm Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.

Liquid Assets

CN¥100.00 Million

≈ $14.63 Million USD Cash + Short-term Investments

Total Assets

CN¥2.43 Billion

≈ $355.23 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2023)

This chart shows how Zhejiang Chimin Pharm Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Chimin Pharm Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Chimin Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Zhejiang Chimin Pharm Co Ltd asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥100.00 Million	4.12%
Total Liquid Assets	CN¥100.00 Million	4.12%

Asset Resilience Insights

Limited Liquidity: Zhejiang Chimin Pharm Co Ltd maintains only 4.12% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Chimin Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Chimin Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Gan & Lee Pharmaceuticals Co Ltd SHG:603087	Medical Instruments & Supplies	9.87%
Kyobo 8 Special Purpose Acquisition Company KQ:307280	Medical Instruments & Supplies	9.73%
Safe Orthopaedics SA PA:ALSAF	Medical Instruments & Supplies	2.20%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%
SDI Ltd AU:SDI	Medical Instruments & Supplies	3.36%
Austco Healthcare Ltd AU:AHC	Medical Instruments & Supplies	15.90%
Trajan Group Holdings Ltd AU:TRJ	Medical Instruments & Supplies	0.29%

Annual Asset Resilience Ratio for Zhejiang Chimin Pharm Co Ltd (2018–2023)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Chimin Pharm Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	4.44%	CN¥110.00 Million ≈ $16.10 Million	CN¥2.48 Billion ≈ $362.90 Million	+1.23pp
2021-12-31	3.20%	CN¥77.68 Million ≈ $11.37 Million	CN¥2.43 Billion ≈ $354.86 Million	-2.41pp
2020-12-31	5.61%	CN¥128.59 Million ≈ $18.82 Million	CN¥2.29 Billion ≈ $335.39 Million	-0.84pp
2019-12-31	6.45%	CN¥134.41 Million ≈ $19.67 Million	CN¥2.08 Billion ≈ $305.03 Million	+0.36pp
2018-12-31	6.09%	CN¥129.47 Million ≈ $18.95 Million	CN¥2.12 Billion ≈ $310.93 Million	--

pp = percentage points

About Zhejiang Chimin Pharm Co Ltd

SHG:603222 China Medical Instruments & Supplies

Market Cap

$678.47 Million

CN¥4.64 Billion CNY

Market Cap Rank

#10763 Global

#2943 in China

Share Price

CN¥8.83

Change (1 day)

+0.68%

52-Week Range

CN¥6.98 - CN¥14.06

All Time High

CN¥57.73